Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall

Recall #D-1052-2022 · 04/13/2022

Class II: Risk

Recall Details

Recall Number
D-1052-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Mckesson Medical-Surgical Inc. Corporate Office
Status
Terminated
Date Initiated
04/13/2022
Location
Richmond, VA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
76 trays/25 vials per tray

Reason for Recall

cGMP deviations: Temperature abuse

Product Description

Xylocaine + Epinephrine, multi dose vial 1%, packaged in a) 20 mL, 25-count box (NDC 63323-482-27) b) 50 mL, 25-count box (NDC 63323-482-57), Rx only, MFG: Fresenius Kabi USA LLC

Distribution Pattern

USA nationwide.

Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office

View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.